Case Status
Active
Case Caption
Alghazwi v. The Beauty Health Company, et al.
Position
Lead Counsel
Practice Areas
Court
U.S. District Court for the Central District of California
Judge Assigned
Sherilyn Peace Garnett
Case Number
2:23-cv-09733-SPG-MAA
Defendant(S)
The Beauty Health Company
Andrew Stanleick
Liyuan Woo
Exchange
NASDAQ
Stock Symbol
SKIN
File Date
Class Period
-
Lead Plaintiff Deadline
Phone

The complaint alleges that Beauty Health failed to disclose that: (1) Syndeo 1.0 and 2.0 devices had issues leading to “frequent treatment interruptions;” (2) as a result, the company incurred significant costs to develop enhancements; (3) despite the enhancements, providers continued to experience issues with Syndeo devices; and (4) as a result, the company would discontinue marketing Syndeo 1.0 and 2.0 devices and incur significant inventory write-downs.

The alleged fraud unraveled on Nov. 13, 2023, when Beauty Health announced disappointing Q3 2023 financial results. The company said “[t]he quarter was overshadowed by lower-than-expected U.S. revenue and $63.1 million in restructuring charges related to device upgrades of early generation Syndeo devices.” The company further slashed its 2023 net sales guidance and suspended its long term 2025 financial outlook and revealed that its CEO (Andrew Stanleick) would be departing effective Nov. 19, 2023.

The complaint alleges an earlier corrective disclosure on Aug. 9, 2023, when Beauty Health revealed that its Q2 2023 gross margins was unfavorably impacted by a mix shift toward lower margin refurbished devices as U.S. providers awaited Syndeo enhancements in Q3 2023 to improve user experience.

CASE TIMELINE

Amended Complaint is filed
Hagens Berman is appointed Lead Counsel

Complaint is filed

Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.